(177)Lu-trastuzumab radionuclide therapy: a promising strategy for trastuzumab-resistant brain metastases in HER2+ breast cancer.

Santos L, Hrynchak I, Sereno J, Ferreira HRS, Silva M, Fonseca A, Almeida R, Teixeira P, Abrunhosa AJ, Gomes CMF

DOI: 10.1186/s43556-026-00573-7
Published: 2026 Sep 14
Container: Molecular biomedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s43556-026-00573-7,
  title = {(177)Lu-trastuzumab radionuclide therapy: a promising strategy for trastuzumab-resistant brain metastases in HER2+ breast cancer.},
  author = {Santos L and Hrynchak I and Sereno J and Ferreira HRS and Silva M and Fonseca A and Almeida R and Teixeira P and Abrunhosa AJ and Gomes CMF},
  year = {2026},
  journal = {Molecular biomedicine},
  doi = {10.1186/s43556-026-00573-7},
  url = {https://doi.org/10.1186/s43556-026-00573-7}
}

RIS

TY  - JOUR
TI  - (177)Lu-trastuzumab radionuclide therapy: a promising strategy for trastuzumab-resistant brain metastases in HER2+ breast cancer.
AU  - Santos L
AU  - Hrynchak I
AU  - Sereno J
AU  - Ferreira HRS
AU  - Silva M
AU  - Fonseca A
AU  - Almeida R
AU  - Teixeira P
AU  - Abrunhosa AJ
AU  - Gomes CMF
PY  - 2026
JO  - Molecular biomedicine
DO  - 10.1186/s43556-026-00573-7
UR  - https://doi.org/10.1186/s43556-026-00573-7
ER  -

APA

L, S., I, H., J, S., HRS, F., M, S., A, F., R, A., P, T., AJ, A., & CMF, G. (2026). (177)Lu-trastuzumab radionuclide therapy: a promising strategy for trastuzumab-resistant brain metastases in HER2+ breast cancer.. Molecular biomedicine. https://doi.org/10.1186/s43556-026-00573-7

Source records

pubmed · retrieved 2026-09-25T22:22:51.562Z